Tuesday, 21/10/2025 · 14:00
London (GMT +1:00)
Cost: Free
Add to calendar
Zoë Mullan
Editor-in-Chief, The Lancet Global Health, and Inclusion & Diversity Lead, The Lancet Group, UK
Zoë Mullan joined The Lancet Global Health as founding Editor-in-Chief in 2013 after working previously as a Senior Editor at The Lancet. She is an Ex-Officio Board Member of the Consortium of Universities for Global Health (USA) and a Scientific Advisory Board member of the Centre for International Health Protection at the Robert Koch Institute (Germany). Between 2013 and 2017, Zoë was a Council Member and Trustee of the Committee on Publication Ethics. She originally trained in Biochemistry at the University of Bath (UK) before joining the publishing industry. Zoë is passionate about health equity, research integrity and publication ethics, and using evidence to improve lives.
Gavin Cleaver
Senior Editor, The Lancet Global Health, and Co-Chair, Gender & Diversity Taskforce, The Lancet Group, UK
Gavin Cleaver joined The Lancet Group as Web Editor in August 2016. Prior to this, he obtained his PhD in Political Theory from Cardiff University (UK) with a focus on theoretical approaches to rights, welfare, and health in a modern political framework. Gavin was an Associate Lecturer at Cardiff University (UK), guest lecturer at the University of West England (UK), and led Cardiff's Master's course on theoretical approaches to the welfare state. He then left academia to take up several positions in journalism across various newspapers and magazines, and after several years leading The Lancet Group's podcast offerings, was appointed Acting Senior Editor at The Lancet Global Health in 2025. Gavin is particularly interested in politics, implementation, policy frameworks, human rights, migrant health, and gender equity.
Lan-Lan Smith
Editor-in-Chief, The Lancet Haematology, Oversight of Gender & Diversity Taskforce, The Lancet Group, and Chair, Sex and Gender Based Analysis workstream of the Gender Equity Taskforce, Elsevier, UK
Lan-Lan Smith is the founding Editor of The Lancet Haematology and was a Senior Editor at The Lancet Oncology from 2011. Prior to joining The Lancet Oncology, she gained a PhD from Cancer Research UK/University College London (UK) and held research posts in the Haemato-Oncology Section at the Institute of Cancer Research (UK) and in the Department of Haematology-Oncology at King's College London (UK).
Taissa Vila
Editor-in-Chief, The Lancet Regional Health—Americas, and Co-Chair, Gender & Diversity Taskforce, The Lancet Group, Brazil
Taissa Vila is based in Rio de Janeiro, Brazil. She joined The Lancet Group in 2021 as the founding Editor-in-Chief of The Lancet Regional Health—Americas. Prior to that, Taissa worked as a postdoctoral researcher at the University of Maryland, Baltimore (USA), and at the University of Texas at San Antonio (USA), investigating drug resistance in fungal infections. She graduated with a BSc in Pharmaceutical Sciences from the Federal University of Rio de Janeiro (Brazil) and obtained both an MSc and a PhD in Cell Biology/Biophysics from the same university. Taissa is co-Chair of The Lancet Group’s Gender and Diversity Taskforce and a member of The Lancet Group’s Group for Racial Equity (GRacE), advocating for equity and diversity within and beyond the organisation. She is particularly interested in health equity, political sciences, and the intersections of determinants of health.